In patients with non-small cell lung cancer, serum APE1 autoantibodies were significantly higher than those in healthy controls, and were closely related to APE1 antigen levels in tumor tissues and peripheral blood (135). This evidence concerns the gene APEX1 and non-small cell lung carcinoma.